(Total Views: 88)
Posted On: 09/23/2025 4:07:40 PM
Post# of 171
NetworkNewsBreaks – NextPlat Corp (NASDAQ: NXPL, NXPLW) Advances Development of ClearMetrX 4.0 With AI-Enhanced Healthcare Analytics
NextPlat (NASDAQ: NXPL, NXPLW), a global consumer products and services company, announced its ClearMetrx subsidiary has entered late-stage development of ClearMetrX 4.0, the next generation of its proprietary healthcare data analytics and reporting software. Scheduled for internal rollout in Q4 2025 and commercialization in the first half of 2026, ClearMetrX 4.0 integrates AI-powered capabilities including revenue forecasting, predictive inventory management, anomaly detection, fraud prevention, audit support, and scenario modeling. The cloud-based platform is already in use across the Company’s pharmacies and client network, streamlining analytics for physicians, MSOs, 340B entities, and pharmacies. NextPlat said the upgrade reflects its commitment to improving healthcare efficiency, compliance, and patient outcomes as global demand for AI-driven healthcare solutions accelerates.
NOTE TO INVESTORS: The latest news and updates relating to NXPL are available in the company’s newsroom at https://nnw.fm/NXPL
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
NextPlat (NASDAQ: NXPL, NXPLW), a global consumer products and services company, announced its ClearMetrx subsidiary has entered late-stage development of ClearMetrX 4.0, the next generation of its proprietary healthcare data analytics and reporting software. Scheduled for internal rollout in Q4 2025 and commercialization in the first half of 2026, ClearMetrX 4.0 integrates AI-powered capabilities including revenue forecasting, predictive inventory management, anomaly detection, fraud prevention, audit support, and scenario modeling. The cloud-based platform is already in use across the Company’s pharmacies and client network, streamlining analytics for physicians, MSOs, 340B entities, and pharmacies. NextPlat said the upgrade reflects its commitment to improving healthcare efficiency, compliance, and patient outcomes as global demand for AI-driven healthcare solutions accelerates.
NOTE TO INVESTORS: The latest news and updates relating to NXPL are available in the company’s newsroom at https://nnw.fm/NXPL
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
(0)
(0)
